Inflammatory Bowel Disease

Top Story

VIDEO: Speaker reviews factors that impact response to treatment for Crohn’s disease, ulcerative colitis

March 28, 2017

NEW YORK — At the Interdisciplinary Autoimmune Summit, Steven B. Hanauer, MD, medical director of the Digestive Health Center at Northwestern University, Feinberg School of Medicine, talked about his presentation on strategies in the management of inflammatory bowel disease.

European Commission approves adalimumab biosimilar for treatment of RA, PsA, AS, JIA

March 27, 2017
The European Commission has approved Amgevita, a biosimilar to adalimumab, for the treatment of moderate to severe rheumatoid arthritis, psoriatic arthritis, severe…
In the Journals Plus

Hyperthyroidism may be associated with ulcerative colitis

March 23, 2017
Adults with ulcerative colitis are more likely to have been previously diagnosed with hyperthyroidism compared with adults without ulcerative colitis, study data from…
In the Journals

Biologics effectively induce, maintain mucosal healing in IBD

March 23, 2017
Anti-TNF agents are effective for maintaining mucosal healing in Crohn’s disease, while anti-TNFs and anti-integrins are comparably effective for inducing and…
CME

Emerging Agents: A Deeper Look

This activity is supported by an educational grant from Receptos.

There are quite a few agents in development for the treatment of ulcerative colitis and Crohn's disease, and many of…
More »
GI Bookshelf

Chapter 6: Infections In IBD - Clostridium difficile and Cytomegalovirus

From Clinical Challenges and Complications of IBD
More »
Featured
Advances in IBD

Advances in IBD

Video
Meeting News

VIDEO: Loftus discusses management of infections in IBD patients

December 13, 2016
More »
Meeting NewsVideo

VIDEO: Speaker reviews factors that impact response to treatment for Crohn’s disease, ulcerative colitis

March 28, 2017
NEW YORK — At the Interdisciplinary Autoimmune Summit, Steven B. Hanauer, MD, medical director of the Digestive Health Center

European Commission approves adalimumab biosimilar for treatment of RA, PsA, AS, JIA

March 27, 2017
The European Commission has approved Amgevita, a biosimilar to adalimumab, for the treatment of moderate to severe rheumatoid arthritis, psoriatic…

In the Journals Plus

Hyperthyroidism may be associated with ulcerative colitis

March 23, 2017
Adults with ulcerative colitis are more likely to have been previously diagnosed with hyperthyroidism compared with adults without ulcerative…

In the Journals

Biologics effectively induce, maintain mucosal healing in IBD

March 23, 2017
Anti-TNF agents are effective for maintaining mucosal healing in Crohn’s disease, while anti-TNFs and anti-integrins are comparably effective…

In the Journals

Five key factors predict high health care use, costs for IBD patients

March 15, 2017
Psychiatric illness, corticosteroid use, narcotic use, low hemoglobin levels and a high number of IBD-related hospitalizations were predictive of…

In the Journals

Researchers identify autoantibody biomarkers in Crohn's disease using immunoproteomics

March 15, 2017
Researchers from the ASU Biodesign Institute and Mayo Clinic have identified an autoantibody biomarker in Crohn’s disease using a novel…

Sherman Prize now accepting nominations for achievements in IBD

March 10, 2017
The Bruce and Cynthia Sherman Charitable Foundation announced that the online nomination period has begun for the second annual Sherman Prize for…

In the Journals

Baker's yeast linked to worsening of symptoms in Crohn's disease

March 9, 2017
Recent study data suggest that the common yeast strain Saccharomyces cerevisiae, also known as Baker’s yeast, may exacerbate Crohn’s…

In the Journals

Immigrant study shows impact of environmental factors in IBD

March 8, 2017
Danish residents who immigrated from the Faroe Islands had about a 25% higher incidence of IBD and a 44% higher incidence of ulcerative colitis than…

In the Journals

Review shows biosimilar infliximab safe, effective in IBD

March 7, 2017
Inflectra demonstrated “excellent clinical efficacy and safety” in patients with inflammatory bowel disease, according to the results of…

More Headlines »
Advertisement
Advertisement